OKYO Pharma Limited (OKYO)

OKYO Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Assets

Fiscal Quarter	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021
Cash & Equivalents	14.59	4.22	1.56	0.99	0.83	-	4.05	0.71	2.7	5.2
Short-Term Investments	6	-	-	-	-	-	-	-	-	-
Cash & Short-Term Investments	20.59	4.22	1.56	0.99	0.83	-	4.05	0.71	2.7	5.2
Cash Growth (YoY)	1219.38%	327.51%	88.78%	-	-79.56%	-	49.79%	-86.42%	-60.73%	-30.24%
Other Receivables	0.17	0.02	1.89	1.52	0.58	-	0.98	0.54	0.88	0.32
Receivables	0.17	0.02	1.89	1.52	0.58	-	0.98	0.54	0.88	0.32
Prepaid Expenses	0.21	0.39	0.23	0.32	0.13	-	0.17	0.52	0.71	0.03
Other Current Assets	-	0	-	0	-	-	-	0	-	0
Total Current Assets	20.97	4.64	3.68	2.83	1.54	-	5.2	1.76	4.3	5.55
Property, Plant & Equipment	0.01	0	0	0	0	-	0.01	0.01	0.01	0.09
Total Assets	20.98	4.64	3.68	2.83	1.54	-	5.2	1.77	4.3	5.64

Liabilities

Fiscal Quarter	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021
Accounts Payable	7.14	7.64	7.9	9.61	6.13	-	2.39	1.52	0.74	0.22
Accrued Expenses	1.5	-	0.38	-	1.19	-	2.65	0.6	0.61	0.37
Short-Term Debt	-	0.19	-	0	-	-	2.22	-	-	-
Current Portion of Leases	-	-	-	-	-	-	-	-	-	0.03
Other Current Liabilities	0	0.23	0.95	0.45	0.1	-	-	-	-	-
Total Current Liabilities	8.64	8.06	9.23	10.05	7.42	-	7.26	2.12	1.35	0.62
Long-Term Leases	-	-	-	-	-	-	-	-	-	0.05
Total Liabilities	8.64	8.06	9.23	10.05	7.42	-	7.26	2.12	1.35	0.67

Shareholders' Equity

Fiscal Quarter	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021
Additional Paid-In Capital	173.56	151.23	146.72	144.05	143.11	-	131.39	87.66	123.98	103.11
Retained Earnings	-151.97	-145.61	-143.02	-145.2	-142.52	-	-125.7	-90.71	-112.43	-100.52
Comprehensive Income & Other	-9.25	-9.03	-9.24	-6.07	-6.47	-	-7.74	2.7	-8.6	2.38
Shareholders' Equity	12.34	-3.42	-5.55	-7.23	-5.88	-	-2.05	-0.35	2.95	4.97
Total Liabilities & Equity	20.98	4.64	3.68	2.83	1.54	-	5.2	1.77	4.3	5.64

Additional Metrics

Fiscal Quarter	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021
Total Debt	-	0.19	-	0	-	-	2.22	-	-	0.08
Net Cash (Debt)	20.59	4.03	1.56	0.99	0.83	-	1.83	0.71	2.7	5.12
Net Cash Growth (YoY)	1219.38%	309.44%	88.78%	-	-54.82%	-	-32.23%	-86.20%	-60.16%	-31.07%
Net Cash Per Share	0.55	0.11	0.03	0.03	0.03	-	0.08	0.03	0.17	0.37
Filing Date Shares Outstanding	52.48	38.45	37.61	33.94	33.84	25.71	25.55	21.77	21.14	14.01
Total Common Shares Outstanding	52.48	38.45	36.02	33.94	33.34	25.71	25.52	21.77	21.14	14.01
Working Capital	12.33	-3.42	-5.55	-7.23	-5.88	-	-2.06	-0.35	2.94	4.93
Book Value Per Share	0.24	-0.09	-0.15	-0.21	-0.18	-	-0.08	-0.02	0.14	0.35
Tangible Book Value	12.34	-3.42	-5.55	-7.23	-5.88	-	-2.05	-0.35	2.95	4.97
Tangible Book Value Per Share	0.24	-0.09	-0.15	-0.21	-0.18	-	-0.08	-0.02	0.14	0.35
Machinery	0.02	0.01	0.01	0.01	0.01	-	0.02	0.01	0.01	0.01

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 12, 2026

Data Sources Report a data error